Product Master Plan. For Product to be Produced by Baxter hereunder, the Parties shall agree in writing upon a Product Master Plan. In no event shall Baxter be required to schedule any Production until a Product Master Plan for such Product has been approved in writing by both Baxter and Client.
Appears in 4 contracts
Samples: Master Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB), Commercial Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB), Master Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB)
Product Master Plan. For Clinical Product or Commercial Product to be Produced by Baxter hereunder, the Parties shall agree have agreed in writing upon a Product Master Plan. In no event Baxter shall Baxter not be required to schedule any Production until a Product Master Plan for such Product has been approved in writing by both Baxter and ClientCelator.
Appears in 3 contracts
Samples: Clinical and Commercial Manufacturing and Supply Agreement (Jazz Pharmaceuticals PLC), Clinical and Commercial Manufacturing and Supply Agreement (Celator Pharmaceuticals Inc), Clinical and Commercial Manufacturing and Supply Agreement (Celator Pharmaceuticals Inc)
Product Master Plan. For Product to be Produced by Baxter hereunder, the Parties shall agree in writing upon a Product Master Plan. In no event shall Baxter will not be required to schedule any or commence Production until a Product Master Plan for such Product has been approved in writing by both Baxter and Client.
Appears in 1 contract
Samples: Clinical Manufacturing and Supply Agreement (Accelerated Pharma, Inc.)
